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Background: There is conflicting evidence about the association between low vitamin D levels in children and
development of asthma in later life. The objective of this study was to systematically review the evidence for an
epidemiological association between low serum levels of vitamin D and the diagnosis of asthma in children.
Methods: We used the Cochrane methodology for conducting systematic reviews. The search strategy included an
electronic search of MEDLINE and EMBASE in February 2013. Two reviewers completed, in duplicate and
independently, study selection, data abstraction, and assessment of risk of bias.
Results: Of 1081 identified citations, three cohort studies met eligibility criteria. Two studies found that low serum
vitamin D level is associated with an increased risk of developing asthma late in childhood, while the third study
found no association with either vitamin D2 or vitamin D3 levels. All three studies suffer from major
methodological shortcomings that limit our confidence in their results.
Conclusions: Available epidemiological evidence suggests a potential association between low serum levels of
vitamin D and the diagnosis of asthma in children. High quality studies are needed to reliably answer the question
of interest.
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Asthma is a highly prevalent respiratory condition in child-
hood [1]. Development of asthma is associated with many
immunological markers [2]. Hypovitaminosis is prevalent
worldwide, and an increasing body of evidence supports
pleotropic effects of vitamin D on various chronic disor-
ders including those associated with immune regulatory
function [3-5]. This includes associations with a number of
childhood disorders [6], such as type I diabetes mellitus
[7-11], celiac disease, and asthma [12,13].
The hypothesis is that vitamin D has immunoregula-
tory properties [14,15] that protect from asthma [16,17].
Vitamin D has been shown to play a role in both the* Correspondence: smroueh@aub.edu.lb
2Department of Pediatrics and Adolescent Medicine, American University of
Beirut, Beirut, Lebanon
Full list of author information is available at the end of the article
© 2014 Rajabbik et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.innate and adaptive immune responses by promoting
phagocytosis and modulating the effect of Th1, Th2 and
regulatory T cells [18]. Vitamin D has also been shown
to inhibit the production of TH17 cytokines, which are
associated with the severity of asthma and low steroid
responsiveness [19]. A number of studies have suggested
that low vitamin D levels are associated with increased
risk of developing asthma [20-22] but other studies failed
to confirm these findings [23,24]. One cohort study has
shown that vitamin D supplementation in childhood
might be associated with an increased risk of developing
asthma [25].
Given these conflicting results and the high prevalence of
both asthma and vitamin D deficiency in many countries
[26,27], we aimed to systematically review the evidence for
the epidemiological association between low levels of serum
vitamin D and asthma diagnosis in children.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Protocol and registration
Prior to starting the review process, we registered the system-
atic review protocol with PROSPERO (CRD42013004204)
[28].
Selection criteria
We included studies meeting the following eligibility
criteria:
 Types of studies: cohort studies. We excluded case–
control studies and cross sectional studies.
 Types of participants: children less than 18 years old
and free of asthma at the time of inclusion in the
cohort. We did not consider other kinds of allergic
conditions.
 Types of exposure: serum vitamin D levels in the
child. We excluded studies of vitamin D levels in the
pregnant mother or in the cord blood at the time of
delivery and studies of vitamin D intake or
supplementation.
 Types of outcome measures: asthma diagnosed based
on doctor’s diagnosis, questionnaires, or spirometry
measures.
We did not exclude studies based on language or date
of publication, but excluded meeting abstracts.
Search strategy
The OVID interface was used to electronically search
MEDLINE and EMBASE (from date of inception to
February 2013). The search strategy was designed
with the help of a medical librarian. The search com-
bined terms for asthma, vitamin D, and pediatric age
group. It used both free text words and medical subject
heading. We did not use any search filter for study design.
Additional file 1 provides the full details of the search
strategy.
In addition, we searched the grey literature (theses and
dissertations) and the abstracts and proceedings from
the following scientific meetings: American Thoracic
Society (ATS), American College of Chest Physicians
(ACCP), Pediatric Academic Societies, European Respira-
tory Society, and European Society for Pediatric Research.
We also reviewed the references lists of included studies
and publications available in the authors’ libraries. We
searched forward for papers citing our included papers
(ISI Web of Science). Finally, we contacted the authors of
included studies inquiring about potentially eligible stud-
ies that we might have missed.
Selection of studies
Two reviewers (LA, MF) screened the titles and abstracts
of identified citations for potential eligibility in duplicateand independently. We obtained the full text for citations
judged as potentially eligible by at least one of the 2 re-
viewers. The two reviewers (LA, MF) then screened the
full texts for eligibility, in duplicate, and independently.
Data collection
Two reviewers abstracted data from included studies in
duplicate and independently. A senior team member
(EAA) provided oversight. For each included study, the
following information was abstracted: type, funding,
population characteristics, exposure, outcomes assessed
and the statistical data.
For both study selection and data collection steps, the
reviewers used a pilot tested and standardized screening
form and detailed instructions and resolved disagree-
ment by discussion. A senior team member (EAA) pro-
vided oversight.
Assessment of risk of bias in included studies
The two reviewers assessed the risk of bias in each in-
cluded study in duplicate and independently. They re-
solved disagreements by discussion or with the help of a
third reviewer (EAA) who provided oversight. Risk of
bias was assessed using the following criteria: [29].
 Failure to develop and apply appropriate eligibility
criteria (e.g., selection of exposed and unexposed in
cohort studies from different populations).
 Flawed measurement of exposure (i.e., serum
vitamin D levels).
 Flawed measurement of outcome (i.e., asthma
diagnosis).
 Failure to adequately control confounding variables
(e.g., failure of accurate measurement of all known
prognostic factors, failure to match for prognostic
factors and/or adjustment in statistical analysis).
 Incomplete follow-up.
We graded each potential source of bias as high, low
or unclear.
Data analysis and synthesis
We used the kappa statistic to calculate the agreement
between the two reviewers for the assessment of trial eligi-
bility. We were not able to meta-analyze the results of the
included studies, as two analyzed vitamin D as a continu-
ous variable [13,24], while the third study analyzed it cate-
gorized into tertiles [12]. We report both unadjusted and
adjusted odds ratios (ORs) where available.
Results
Description of study selection
Figure 1 shows the study flow. Out of 39 potentially eli-
gible studies, three met our eligibility criteria [12,13,24].
Additional records identified 
through other sources (n = 116)
Records after duplicates removed (n =1083)
Records identified through database 
searching (n = 967)




Full-text articles assessed for 
eligibility
(n = 39)
Studies included in qualitative 
synthesis
(n = 3)
Studies included in quantitative 
synthesis (meta-analysis) (n = 
0)
Full-text articles excluded, with 
reasons (n=36)
Case Control Study ( n = 8 )
Cross sectional Study ( n = 14 )
Subjects had asthma at enrolment 
( n = 3)
Assessing Vit. D Intake (n = 1)
Assessing Vit. D supplementation 
( n = 3)
Assessing Vitamin D as effect 
modifier for steroids ( n = 1 )
Assessing cord Blood vitamin D 
levels ( n = 1 )
Not assessing asthma as the 
outcome ( n = 1 )
Meeting abstract ( n = 2 )























Figure 1 Study flow.
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Study characteristics
Table 1 lists the characteristics of the included studies.
All three studies used data collected in the context of lar-
ger cohort studies conducted in the late 1980’s and 1990’s.
The first study was conducted in Australia and included a
population of 989 six-year-old subjects followed up until
14 years of age. The second one was conducted in the
Netherlands and included a population of 372 four-year-
old subjects followed up until 8 years of age. The last
study was conducted in England and included a popula-
tion of 3,323 children with a mean age of 9.8 years and
followed up until a mean age of 15.5 years.
Risk of bias
Table 2 describes the assessment of the risk of bias in
those studies. In our judgment, the risk of bias associ-
ated with subject selection in the study by Van Oeffelen
et al. was high as only a small percentage of the incep-
tion cohort was assessed in this study. The risk of biasassociated with measurement of the exposure (Vitamin
D levels) in the Van Oeffelen study was high due to the
use of tests for which no validation is described, and due
to the low reliability of a single measurement. The risk
of bias associated with the outcome measurement
(asthma) was low for both the Hollams et al. and Van
Oeffelen et al. studies and uncertain for the Tolppanen
et al. study in which non-validated questionnaires were
used to diagnose asthma. We judged the risk of bias as-
sociated with confounding as high in one study due to
lack of adjustment (Hollmans et al.). The risk of bias asso-
ciated with missing data was judged as high in two studies
due to high rates of missing data (30% for Hollams et al.
and 42% for Tolppanen et al.).
Statistical results
Asthma
Hollams et al. [13] found an unadjusted OR for the asso-
ciation between increasing vitamin D levels and risk of
asthma of 0.11 (95% CI 0.02–0.84). Van Oeffelen et al.
found an adjusted OR of 0.39 (95% CI 0.27–0.53) when
comparing vitamin D tertile 2 to tertile 1 (the lowest
Table 1 Characteristics of included studies
Study name, Funding Study design Participants Exposure Outcome Notes
• Hollams [13] • Prospective birth
cohort started in
1989
• Conducted as part of West Australian
Pregnancy Cohort (Raine Study):
a longitudinal birth cohort, in which
mothers (2900 volunteers) were enrolled
for antenatal care at the main local tertiary
maternity hospital
• Serum 25-hydroxyvitamin
D levels measured at the
age of 6 years
• Current asthma; defined as
wheeze plus use of any
asthma medication in the
last 12 months, in children
with a prior doctor
diagnosis of asthma
• Vitamin D levels at age 6
years (Continuous outcome)
analyzed as a predictor of
subsequent clinical
phenotypes at 14 years of
age
Source of funding not reported
• Follow up:
8 years





• 8 years period between the
point of measuring vitamin
D levels and the assessment
of asthma
• Reference group: sufficient
level of vit D (> 75)
• Included in this study: 989 children
assessed at the age of 6 (no further details
provided about selection criteria or
process); 693 were included in the analysis. • Vitamin D values were
‘deseasonalized’





• Perth, Western Australia, Australia
• Outcomes assessed at the
age of 14 years
Van Oeffelen [12] • Prospective birth
cohort started in
1996
• Conducted as part of PIAMA birth cohort
of 3963 newborns; pregnant women
recruited from the general population
when visiting one of 52 prenatal clinics
• Serum 25-hydroxyvitamin
D levels measured at the
age of 4 years
• Asthma and severe asthma
diagnosed using the (ISAAC)
[29] questionnaire answered
by parents annually until
8 year of age
• Vitamin D levels categorized
into tetriles (Reference:
tertile 1)
Funded by the Netherlands
Organisation for Health Research and
Development, the Netherlands
Asthma Foundation, the Netherlands
Ministry of Health, Welfare and Sport,
and the National Institute of Public
Health and the Environment.
• Follow up:
5 years
• Serum extracted and
directly stored in a
refrigerator at -20C, and
defrosted in 2008 to
measure of vit. D levels





• 4 years period between the
point of measuring vitamin
D levels and the assessment
of asthma
• Included in this study: 372 “selected” 4-
year-old children (no further details pro-
vided about selection criteria or process);
all were included in the analysis
• Storage time of serum
samples proved to be no
confounder and was
therefore not added to the
models.
• Categorized into tertiles
(range; median): • Bronchial hyperrsponsiveness
(BHR) measured at 8 years of
age; assessed by
methacholine challenge
o Tertile 1: 23.1–60.2; 52.0
o Tertile 2: 60.7–78.8; 68.3 • Vitamin D values were
‘deseasonalized’
Netherlands





















Table 1 Characteristics of included studies (Continued)
Tolppanen [22] • Prospective birth
cohort started in
1991
• Conducted as part of the Avon
longitudinal Study of Parents and children
(ALSPAC): 14,062 live births from 14,541
enrolled pregnant women who were
expected to give birth between 1st of April
1991 and 31st of December 1992
• Serum 25-hydroxyvitamin
D2 and D3 levels
measured at a mean
age of 9.8 years
• Asthma and wheezing
assessed (questionnaire to
children) at the age of
15-16 years.
• Asthma and wheezing also
assessed on a yearly basis
(questionnaire to caregiver);
not clear whether those data
were included in the analysis
Funded by the UK Medical Research
Council, the Wellcome trust, and the
University of Bristol • Follow up:
6 years • 5-6 years period between
the point of measuring vita-
min D levels and the
assessment of asthma
• Measured using high
pressure liquid
chromatography tandem
mass spectrometer in the
multiple reaction mode
• The exposures are
standardized for age and
sex and 25(OH)D3 is
adjusted for season and
ethnicity
• Interassay coefficients of
• Variation for 25(OH)D2 and
25(OH)D3 were < 10%
across a working range of
1–250 ng/ml
• Lung function measured at a mean age of
15.5 years by spirometry according to the
American Thoracic Society/European
respiratory Society criteria. The best
measurements from three reproducible
flow-volume curves were used for analyses
• Included in this study
(mean age of 9.8): 3323
children for the asthma
outcome and 2,259 for
spirometry (inclusion based
on completeness of data on
exposures, confounders, and
outcome)





















Table 2 Risk of bias in included studies; each criterion was graded as high, low, or unclear risk
Study name Developing and applying
appropriate eligibility criteria
Measurement of exposure Measurement of outcome Controlling for
confounding
Completeness of data
• Hollams [13] • Uncertain risk • High risk • Low risk • High risk • High Risk
• Although the risk of bias is low
for the original cohort, no
further details were provided
about selection criteria or
process for participants in this
current study
• “Vit D levels was measured in thawed
serum cryobanked at age 6 years”
(number of years since blood draw not
mentioned)





• Outcome data were missing
for 30% of the enrolled
cohort
• The used enzyme immunoassay kit
“method appeared to overestimate the
vitamin D levels at age 6 years”
• Measuring Vitamin D levels at one
point only may not be a reliable
measure of integrated 25(OH) D levels
over time
Van Oeffelen [12] • High risk • High risk • Low risk • Low risk • Uncertain Risk
• Out of the larger cohort, a small
“selected” sample included in
this study, with no further
details about selection provided
• Serum samples were defrosted to
measure concentrations of Vitamin D
(number of years since blood draw not
mentioned)
for asthma (ISAAC score) Low risk for
BHR
• Confounders were added to
all models (gender, maternal
atopy, paternal atopy,
smoking by anyone in the
house, and serum
magnesium)
• Outcome data were missing
for 12% of the enrolled
cohort
• Measured using a competitive enzyme
immunoassay in microtiter plates
• Measuring Vitamin D levels at one
point only may not be a reliable
measure of integrated 25(OH) D levels
over time
• Also considered playing
outside and overweight as
potential confounders
Tolppanen [22] • Uncertain risk • High risk • Uncertain risk for asthma, using
spirometry & bronchidilatory
responsiveness with non-validated
questionnaires to diagnose asthma
• Low risk • High risk
• Except for the loss of follow up,
the cohort was from a single
community and followed
specific eligibility criteria
• The exposures are standardized for age
and sex and 25-hydroxyvitamin D3 is
adjusted for season and ethnicity
• Model 1 unadjusted • Of 5765 participants in the
assessment of the wheezing
and asthma outcome 3323
where included (42%
missing data)• Measured using high pressure liquid
chromatography tandem mass
spectrometer in the multiple reaction
mode (number of years since blood
draw not mentioned)
• High risk for wheezing • Models 2 and 3 adjusted for
respectively 8 and 9
potential confounders• Recall bias • And of 4488 participants in
the spirometric assessment
2259 where included (50%
missing data).
• Measuring Vitamin D levels at one
point only may not be a reliable
measure of integrated 25(OH) D levels
over time
• Proportion of incident
wheezing, and asthma was
higher among children
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when comparing tertile 3 to tertile 1 (see Table 2 for
variables used for adjustment) [12]. Tolppanen et al.
found no association between vitamin D3 and asthma
with an adjusted OR of 1.02 (95% CI 0.93–1.12) and an
unadjusted OR of 0.98 (95% CI 0.92–1.05) [24]. Simi-
larly, they found no association between vitamin D2 and
asthma with an adjusted OR of 0.89 (95% CI 0.78–1.02)
and an unadjusted OR of 0.98 (95% CI 0.89–1.08) (see
Table 2 for variables used for adjustment). Hollams et al.
also assessed the association between increasing vitamin
D levels and severe asthma and found an OR of 0.28 (95%
CI 0.06–1.37).
Spirometric outcomes
Both Hollams et al. and van Oeffelen et al. assessed bron-
chial hyperresponsiveness using the methacholine chal-
lenge test. Hollams et al. [13] found an unadjusted OR for
the association between increasing vitamin D levels and
bronchial hyperresponsiveness of 0.28 (95% CI 0.06–1.37).
Van Oeffelen [12] found an adjusted OR of 0.72 (95% CI
0.39–1.35) when comparing vitamin D tertile 2 to tertile 1,
and an adjusted OR of 0.66 (95% CI 0.35–1.25) when com-
paring tertile 3 to tertile 1 (see Table 2 for variables used
for adjustment).
Tolppanen et al. assessed lung function through the
bronchodilator response to 400 ug dose of salbutamol.
They reported the results using “SD change in outcome
per doubling of exposure” [24]. This refers to reporting a
standardized measure of the lung function outcome
(typically equivalent to the mean divided by standard de-
viation) for every “doubling of exposure”. The authors
calculated the doubling of exposure after scaling the two
forms of 25(OH) D by multiplying the beta coefficients
from the regression models by loge. The highest SD
change reached among all analytical models was 0.06,
which is typically considered a small effect size.
Discussion
Summary of main results
In summary, our systematic review identified three co-
hort studies assessing the association between low vita-
min D levels in children and the incidence of asthma.
Two of the included studies reported results suggesting
that lower levels of vitamin D during childhood are asso-
ciated with later development of asthma [12,13]. The third
one found no association with either vitamin D2 or D3
levels [24]. Besides the inconsistent results, all three in-
cluded studies suffered from major methodological limita-
tions that limit our confidence in their findings. They all
suffered to different degrees from selection bias (e.g., un-
clear selection criteria), inadequate measurement of the
outcome (e.g., non-validated questionnaires), confounding
(e.g., inadequate adjustment for potential confounderssuch as maternal atopy), and incompleteness of outcome
data 12%-50% of subjects in the three studies had missing
data). The risk of bias associated with exposure measure-
ment was common to the three studies. Indeed, and as
detailed in Table 2, vitamin D was measured once, be-
tween 5–8 years depending on the study, before the as-
sessment of the outcomes, thus limiting the reliability of
the value obtained as a reflection of integrated vitamin D
nutritional status over the follow-up time [30]. In addition,
the methods of handling the samples (e.g., thawing pro-
cedure) may have affected the accuracy of the results. Our
confidence in the findings is further decreased by the im-
precision of the results as indicated by the wide confi-
dence intervals that include the value of 1 for most odds
ratios.
Overall completeness and applicability of evidence
Autier et al. recently published a systematic review of
“vitamin D status and ill health” [31]. Although the re-
viewers included prospective cohort studies, they did
not capture any of the studies we included in our review.
This makes the possibility that we missed eligible studies
unlikely. We have excluded studies of cord blood vita-
min D levels because cord blood in part reflects mater-
nal exposure, and evidence of their correlation with
actual vitamin D levels during childhood is lacking. Also,
we only included cohort studies to minimize the risk of
bias in the results of this review. However, we observed
that studies we excluded for their study design, and de-
scribed as “case–control”, were actually cross-sectional
in nature. Indeed, these studies assessed both the expos-
ure (vitamin D level) and the outcome (asthma) simul-
taneously at the time of inclusion into the study.
Agreements and disagreements with other reviews
Recently, Theodoratou et al. published an umbrella review
that included systematic reviews and meta-analyses of ob-
servational studies of vitamin D and multiple health out-
comes [32]. They identified no published systematic review
or meta-analysis assessing the asthma outcome. We identi-
fied two systematic reviews [33,34] and two narrative re-
views related to our study [35,36]. Neither of the two
systematic reviews identified the studies we included in our
review. The systematic review by Nurmatov et al. included
studies related to maternal levels of vitamin D as opposed
to children’s levels’. Most of the studies systematic review
by Zhang et al. were either studies of chronic obstructive
pulmonary disease or non-cohort studies [34]. The one co-
hort study of asthma that they included measured cord
blood levels [37]. The narrative review by Gupta et al. ad-
dressed a range of questions around vitamin D and asthma
in children [35]. That review did not include any of the
three studies we included. The narrative review by Hollmas
[36] identified only one of the three included studies [13].
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The finding of a possible association between lower vita-
min D levels and incidence of asthma may imply that vita-
min D supplementation may be effective in preventing
asthma. However, the considerable uncertainty regarding
the validity of this association precludes at this point any
translation of the findings into clinical practice. Indeed,
we have identified 12 ongoing trials posted on clinical-
trials.gov that are assessing the effects of vitamin D sup-
plementation in children with asthma symptoms.
Implications for research
Future studies should address the methodological limita-
tions of the available evidence. This includes proper as-
sessment of the exposure, by assessing vitamin D status by
multiple measurements throughout the study period, and
accounting for seasonal variation and other environmental
factors. It also requires setting appropriate eligibility cri-
teria, valid measurement of outcomes, controlling for all
confounders, and minimizing missing data.
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